Emcure Pharma IPO Subscription Status

Emcure Pharma IPO Subscription Status
Emcure Pharma IPO subscription started on 3 July, 2024 and will close on 5 July, 2024. The retail quota is 35%, QIB is 50% and NII is 15%. Emcure Pharma IPO got a lot of interest, raising around ₹1952.03 Crores, with subscriptions 67.84 times overall, including 191.24 times by institutional investors, 49.28 times by non-institutional investors, and 7.33 times by retail investors. Shares are priced between ₹960-1008 each and will be listed on the BSE and NSE.
  Check Live IPO  Subscription List  👈
Listed
Last Updated - July 5, 2024 5:39 pm

Emcure Pharma IPO Subscription - Day 3

QIB - Qualified Institutional Buyers: 191.24x
NII - Non-Institutional Investors: 49.28x
SNII - Small Non-Institutional Investors: 38.04x
BNII - Big Non-Institutional Investors: 54.90x
RII - Retail Individual Investor: 7.33x
Total: 67.84x 👈

Emcure Pharma IPO Investor Categories

  • Qualified Institutional Buyers: QIB
  • Non-Institutional Investors: NII
  • Small Non-Institutional Investors: SNII- Bid below ₹10L
  • Big Non-Institutional Investors: BNII- Bid above ₹10L
  • Retail Individual Investor: RII
  • Employees Quota: EMP

Emcure Pharma IPO Dates

IPO Activity Date
Open Date: 3 July, 2024
Close Date: 5 July, 2024
Allotment Date: 8 July, 2024
Refund Date: 9 July, 2024
Shares Credit Date: 9 July, 2024
Listing Date: 10 July, 2024

Emcure Pharma IPO Subscription Status FAQs

Q.When Emcure Pharma IPO Subscription will start?

Ans.The IPO subscription starts on 3 July, 2024 for Investors.


Q.What is the Emcure Pharma IPO Subscription last date?

Ans.Emcure Pharma IPO subscription last date is 5 July, 2024 for Investors.


Q.What is the Emcure Pharma IPO Allotment Date?

Ans.Emcure Pharma IPO allotment date is 8 July, 2024.


Q.What is the Emcure Pharma IPO Listing Date?

Ans.Emcure Pharma IPO listing date is 10 July, 2024. The IPO is to list on BSE and NSE.

Leave a Comment

Your email address will not be published. Required fields are marked *